Hanna L Kleiboeker

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Extracorporeal Membrane Oxygenation

Intellectual Disability

Kidney Transplantation

Epstein Barr Virus

Top Venues

Transplant infectious disease : an official journal of the Transplantation Society

The Annals of pharmacotherapy

Clinical transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Hanna L Kleiboeker, Alyson Prom, Sonalie Patel
Efficacy of dose-reduced glecaprevir-pibrentasvir in lung transplant recipients on maintenance cyclosporine from donors with hepatitis C viremia. Transplant infectious disease : an official journal of the Transplantation Society (2024)
Hanna L Kleiboeker, Alyson Prom, Krista Paplaczyk
Development of cytomegalovirus resistant to maribavir: real world, real problem? Transplant infectious disease : an official journal of the Transplantation Society (2024)
Hanna L Kleiboeker, Jacob Wang, Nicole Borkowski, Brad Miner, Alyson Prom, Krista Paplaczyk, Jennifer Wright, Mrinalini Venkata Subramani, Ambalavanan Arunachalam, Alan D Betensley, Rade Tomic, Catherine N Myers
Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society (2024)
Hanna L Kleiboeker, Alyson Prom, Krista Paplaczyk
Development of cytomegalovirus resistant to maribavir: real world, real problem? Transplant infectious disease : an official journal of the Transplantation Society 26 (2) (2024)
Hanna L Kleiboeker, Alyson Prom, Krista Paplaczyk
Development of cytomegalovirus resistant to maribavir: real world, real problem? Transplant infectious disease : an official journal of the Transplantation Society 26 (2) (2024)
Margaret R Jorgenson, Sandesh Parajuli, Hanna L Kleiboeker, Daniel C Felix, Brad C Astor, Christopher M Saddler, Jeannina A Smith, Didier A Mandelbrot
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern era. Clinical transplantation (2023)
Hanna L Kleiboeker, Alyson Prom, Krista Paplaczyk, Catherine N Myers
A Complement to Traditional Treatments for Antibody-Mediated Rejection? Use of Eculizumab in Lung Transplantation: A Review and Early Center Experience. The Annals of pharmacotherapy (2023)
Hanna L Kleiboeker, Margaret R Jorgenson, Jeannina A Smith
Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19: A case series. Transplant infectious disease : an official journal of the Transplantation Society (2022)
Hanna L Kleiboeker, Margaret R Jorgenson, Jeannina A Smith
Belatacept may result in profound and persistent loss of cytomegalovirus-specific cell-mediated immunity: A case report. Transplant infectious disease : an official journal of the Transplantation Society 24 (2) (2022)
Hanna L Kleiboeker, Jillian L Descourouez, Lucas T Schulz, Didier A Mandelbrot, Jon S Odorico, John P Rice, Christopher M Saddler, Jeannina A Smith, Margaret R Jorgenson
Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations. The Annals of pharmacotherapy (2022)